Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Each pen contains 3 mL of solution
Eligible patients entered run-in phase where any OAD other than metformin were stopped and patients were prescribed glargine
Compounded semaglutide and tirzepatide formulations are not individually FDA-approved products, though they use the same active ingredients
Cannot be combine with other promotions
As of March 2024, there are more than 16 compounds being developed by 11 different companies in late-stage development (phase II or III), an additional 18 compounds in phase I, and approximately 40 in pre-phase I development
For more information on month to month pricing or for maintenance dose pricing after your initial three month committment, please visit identid.com/pricing/, email us at [email protected], or call us at (888) 383-8839
US$ 24.15
US$ 28.41
US$ 21.16
US$ 20.64
